The U.K. Health Security Agency has recorded 111 cases of unexplained hepatitis in children under 10 since January. Ten of the children needed liver transplants.
The new regulations, which govern the Patented Medicine Prices Review Board, will lower pharmaceutical industry profits by $2.9 billion over a decade, rather than the $8.8 billion anticipated previously.
Co-author Dr. David Fisman, of the University of Toronto's Dalla Lana school of public health, said the message of the study is that the choice to get vaccinated can't be thought of as merely personal.
The U.N. health agency said late Saturday that it has so far received reports of at least 169 cases of "acute hepatitis of unknown origin'' from a dozen countries.
The PromoVac strategy, developed in Sherbrooke by Dr. Arnaud Gagneur to convince parents who are hesitant about vaccination, will be deployed across Canada through a telehealth platform.